Prostate Cancer - Results from #26560

Novel options for the treatment of castration-resistant prostate cancer - Abstract January 3, 2012

Comparing how significantly the pharmacological treatment of genitourinary cancer in a non-curative setting affects endpoints of survival or response - Abstract January 3, 2012

Inflammation and endothelial activation in benign prostatic hyperplasia and prostate cancer - Abstract December 23, 2011

Biomarkers in the management and treatment of men with metastatic castration-resistant prostate cancer - Abstract December 23, 2011

Prostate cancer in the senior men from rural areas in east district of China: Contemporary management and 5-year outcomes at multi-institutional collaboration - Abstract December 23, 2011

Early incontinence after radical prostatectomy: A community based retrospective analysis in 911 men and implications for preoperative counseling - Abstract December 23, 2011

Inverse relationship between biochemical outcome and acute toxicity after image-guided radiotherapy for prostate cancer - Abstract December 22, 2011

A double-blind placebo-controlled randomized clinical trial with magnesium oxide to reduce intrafraction prostate motion for prostate cancer radiotherapy - Abstract December 22, 2011

Percentage of positive biopsy cores: A better risk stratification model for prostate cancer? - Abstract December 22, 2011

Prostatic carcinomas with neuroendocrine differentiation diagnosed in needle biopsies, a morphologic study of 7 cases among 465 sequential biopsies in a tertiary cancer center - Abstract December 22, 2011

Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection - Abstract December 22, 2011

Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: Results from the SEARCH database - Abstract December 21, 2011

Ciprofloxacin as a prophylactic agent against prostate cancer: A "two hit" hypothesis - Abstract December 21, 2011

Methods of verifying the output of the treatment planning system used for high dose rate (HDR) prostate brachytherapy - Abstract December 21, 2011

Indications for pelvic nodal treatment in prostate cancer should change. Validation of the Roach formula in a large extended nodal dissection series - Abstract December 21, 2011

Intensity-modulated radiotherapy causes fewer side effects than three-dimensional conformal radiotherapy when used in combination with brachytherapy for the treatment of prostate cancer - Abstract December 21, 2011

Detection, localisation and characterisation of prostate cancer by Prostate HistoScanning™ - Abstract December 20, 2011

New treatment paradigm for prostate cancer: Abarelix initiation therapy for immediate testosterone suppression followed by a luteinizing hormone-releasing hormone agonist - Abstract December 20, 2011

African American men significantly underestimate their risk of having prostate cancer at the time of biopsy - Abstract December 20, 2011

Updating risk prediction tools: A case study in prostate cancer - Abstract December 20, 2011

Page 1329 of 1435